We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

119 hedge funds and large institutions have $1.02B invested in AnaptysBio in 2019 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

64% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 33

10% more call options, than puts

Call options by funds: $20.3M | Put options by funds: $18.6M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4.36% less ownership

Funds ownership: 111.73% → 107.36% (-4.4%)

6% less funds holding

Funds holding: 127 → 119 (-8)

30% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 23

40% less capital invested

Capital invested by funds: $1.7B → $1.02B (-$687M)

Holders
119
Holders Change
-8
Holders Change %
-6.3%
% of All Funds
2.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
54
Reduced
33
Closed
23
Calls
$20.3M
Puts
$18.6M
Net Calls
+$1.77M
Net Calls Change
+$7.31M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$10.9M
2
Morgan Stanley
Morgan Stanley
New York
+$9.19M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$7.67M
4
BI
BVF Inc
California
+$7.07M
5
State Street
State Street
Massachusetts
+$6.35M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$36M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$32.2M
3
Citadel Advisors
Citadel Advisors
Florida
-$13.1M
4
Viking Global Investors
Viking Global Investors
Connecticut
-$10.6M
5
Jennison Associates
Jennison Associates
New York
-$9.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital International Investors
26
Capital International Investors
California
$5.66M – – –
Goldman Sachs
27
Goldman Sachs
New York
$5.29M +$1.31M +27,576 +22%
Charles Schwab
28
Charles Schwab
California
$5.13M +$353K +7,412 +5%
BBA
29
Baker Bros. Advisors
New York
$3.96M – – –
Hudson Bay Capital Management
30
Hudson Bay Capital Management
Connecticut
$3.52M +$866K +18,200 +22%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.48M -$20.1K -422 -0.4%
UBS AM
32
UBS AM
Illinois
$3.48M -$120K -2,516 -2%
N
33
Nuveen
North Carolina
$3.47M -$4.19K -88 -0.1%
Two Sigma Investments
34
Two Sigma Investments
New York
$2.98M +$1.93M +40,526 +91%
Axa
35
Axa
France
$2.39M -$39.9K -838 -1%
TCM
36
Tekla Capital Management
Massachusetts
$2.36M -$347K -7,302 -10%
Rafferty Asset Management
37
Rafferty Asset Management
New York
$2.09M +$949K +19,948 +50%
JP Morgan Chase
38
JP Morgan Chase
New York
$2.05M +$118K +2,470 +4%
AG
39
Advisor Group
Arizona
$1.98M +$95 +2 +0%
AA
40
ALPS Advisors
Colorado
$1.89M -$125K -2,636 -5%
Two Sigma Advisers
41
Two Sigma Advisers
New York
$1.79M +$257K +5,400 +12%
CS
42
Candriam SCA
Luxembourg
$1.75M -$952K -20,000 -29%
California Public Employees Retirement System
43
California Public Employees Retirement System
California
$1.62M +$1.02M +21,400 +86%
CM
44
Caption Management
Oklahoma
$1.61M +$2.19M +46,000 New
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.6M +$19K +400 +0.9%
State of New Jersey Common Pension Fund D
46
State of New Jersey Common Pension Fund D
New Jersey
$1.48M -$609K -12,800 -23%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.34M +$21.7K +457 +1%
UBS Group
48
UBS Group
Switzerland
$1.3M +$865K +18,170 +95%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.29M +$290K +6,100 +20%
AllianceBernstein
50
AllianceBernstein
Tennessee
$1.28M +$38.1K +800 +2%
1
2
3 4 5

ANAB Hedge Fund Activity: Q3 2019 in Review

119 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2019, worth a combined $1.02B — down 40% from $1.7B a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of ANAB and 16 opened new positions — a net loss of 7 holders — while 33 trimmed existing stakes and 54 added.

The largest buyer was Vanguard Group, adding an estimated $10.9M. The largest seller was Invesco, cutting an estimated $36M.

  • 119 institutional investors held AnaptysBio (ANAB) as of Q3 2019, down from 127 in Q2 2019.
  • Funds reported $1.02B of AnaptysBio stock for Q3 2019, down 40% quarter-over-quarter.
  • 16 funds opened new AnaptysBio positions in Q3 2019 and 23 closed out, a net change of -7 holders.
  • The largest AnaptysBio buyer in Q3 2019 was Vanguard Group, an estimated $10.9M added.
  • The largest AnaptysBio seller in Q3 2019 was Invesco, an estimated $36M sold.

Based on aggregated 13F filings for Q3 2019.